Regenxbio (RGNX) Treasury Shares (2014)

Regenxbio's Treasury Shares history runs 10 years deep, the most recent figure standing at $2.8 million for Q4 2025.

• In Q4 2025, Treasury Shares rose 39.57% year-over-year to $2.8 million; the TTM figure through Dec 2025 stood at $2.8 million (up 39.57% YoY), while the FY2025 annual figure was $2.8 million, up 39.57% from the prior year.
• Treasury Shares for Q4 2025 stood at $2.8 million, down from $2.9 million in the prior quarter.
• The five-year high for Treasury Shares was $3.0 million in Q2 2025, with the low at $254000.0 in Q1 2021.
• The 5-year median for Treasury Shares is $1.4 million (2023), against an average of $1.4 million.
• The sharpest annual moves came in 2023 and 2024: Treasury Shares surged 200.42% in 2023, then grew 17.13% in 2024.
• Regenxbio's Treasury Shares stood at $277000.0 in 2021, then surged by 121.3% to $613000.0 in 2022, then jumped by 113.54% to $1.3 million in 2023, then jumped by 56.0% to $2.0 million in 2024, then surged by 39.57% to $2.8 million in 2025.
• Business Quant data shows RGNX's Treasury Shares at $2.8 million in Q4 2025, $2.9 million in Q3 2025, and $3.0 million in Q2 2025.